Meticulous Research®, a leading global market research company, has published a report titled, “North America NGS Automation Market by Product, Sequencing Type, Application, End User - Forecast to 2030.” According to this report, the North America NGS automation market is projected to grow at a compound annual growth rate (CAGR) of 14%, reaching $776.1 million by 2030.

Download Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5736

The market's growth is primarily driven by the increasing prevalence of cancer, the rising demand for Next-Generation Sequencing (NGS) automation in laboratories, the need for optimized and streamlined workflows, and growing pharmaceutical R&D investments coupled with higher healthcare expenditures. Additionally, the expanding applications of NGS technology and collaborative efforts among vendors to develop advanced library preparation protocols are expected to create significant growth opportunities. However, the high cost of automation workstations may restrain market growth to some extent.

Market Segmentation
The North America NGS automation market is segmented by product, sequencing type, application, end user, and country.

• By Product: The market includes workstations/robotic platforms and reagents & consumables. In 2024, the workstations/robotic platforms segment is expected to dominate the market, driven by the advantages of automation in NGS, such as high efficiency, reduced turnaround time, lower per-sample costs, and increased reproducibility compared to manual methods. The high demand for NGS automation in pharmaceutical and biotechnology companies for drug discovery also contributes to this segment's growth.

Brows In Depth: https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736

• By Sequencing Type: The market is divided into whole genome sequencing, whole exome sequencing, targeted genome sequencing, and other sequencing types. The whole genome sequencing segment is expected to hold the largest market share in 2024, attributed to its growing use in identifying novel drug targets and developing targeted therapies, gene therapies, and oligonucleotide therapies.
• By Application: The market covers drug discovery, clinical diagnostics (including reproductive health, oncology, and infectious disease diagnostics), and other applications. The drug discovery segment is expected to account for the largest share in 2024, driven by the increasing use of NGS in identifying novel drug targets and developing therapies targeting specific genes and proteins.
• By End User: The market includes pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and other end users. In 2024, pharmaceutical and biotechnology companies are expected to lead the market, fueled by rising R&D expenditures and the growing demand for new drug discoveries using advanced technologies.
• By Country: The report highlights that the U.S. is expected to hold the largest share of the North America NGS automation market in 2024. This dominance is attributed to the significant R&D investments by the pharma and biotech industry, the presence of leading NGS automation platform providers, supportive government initiatives for genomics research, growing applications of NGS-based research, increased awareness of NGS-based tests, rising cancer prevalence, and a favorable reimbursement scenario.

Quick Buy – North America NGS Automation Market – Opportunity Analysis and Industry Forecast (2024-2030), Research Report: https://www.meticulousresearch.com/Checkout/75503538

Key Players
Key players in the North America NGS automation market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech (U.K.), Thermo Fisher Scientific Inc. (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland).

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research